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Abstract
There is an urgent need for improved models for cardiotoxicity testing. Here we propose
acoustic sensing applied to beating human cardiomyocyte clusters for non-invasive, surro-
gate measuring of the QT interval and other characteristics of the contractile machinery. In
experiments with the acoustic method quartz crystal microbalance with dissipation monitor-
ing (QCM-D), the shape of the recorded signals was very similar to the extracellular field po-
tential detected in electrochemical experiments, and the expected changes of the QT
interval in response to addition of conventional drugs (E-4031 or nifedipine) were observed.
Additionally, changes in the dissipation signal upon addition of cytochalasin D were in good
agreement with the known, corresponding shortening of the contraction-relaxation time.
These findings suggest that QCM-D has great potential as a tool for cardiotoxicological
screening, where effects of compounds on the cardiomyocyte contractile machinery can be
detected independently of whether the extracellular field potential is altered or not.
Introduction
Heart failure and arrhythmias are the major causes of morbidity and mortality in many coun-
tries. Besides genetic and life style reasons, many adverse cardiac events are induced by detri-
mental off-target effects of non-cardiac drugs [1]. To reduce the number of drug-induced
arrhythmias and other functional deficiencies, there is an increasing demand for further devel-
opment of cardiotoxicity assays using human material for evaluating existing and new chemical
entities in pre-clinical studies.
In cardiotoxicology research, cell models used for drug screening should be species relevant,
provide high reproducibility, and exhibit specific markers and functional similarities to adult
human cardiac myocytes. All of these features have been demonstrated for cardiomyocytes
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derived from human pluripotent stem cells (hPS) [2–4], including diseased phenotypes [5].
Specifically, spontaneously beating hPS-derived cardiomyocytes in a cluster format (CMC) can
be obtained in large volumes and have become interesting for toxicology research [6,7]. These
cell clusters range in size from 200–300 μm in diameter and exhibit specific markers and func-
tional similarities to adult human cardiac myocytes [8]. They are considered to be an excellent
in vitro tool for studies of human cardiomyocyte function and are applied for pre-clinical cardi-
ac safety pharmacology assays [9–15].
The combination of appropriate cells and suitable assay formats is a key to successful drug
discovery, as well as to increase the fundamental understanding of cell properties. With respect
to assay development, there is a need for real-time, label-free monitoring (also referred to as
sensing) of rare cell function using array formats. Towards this end, advances have been made
with respect to detection of changes in optical or electrochemical properties of cells [15–17],
whereas techniques directly measuring changes in the mechanical properties of cells in vitro
are largely lacking. The tight link between mechanical properties of cells and important cell
processes (e.g. chronotropic events) suggests that acoustic methods (probing viscoelastic prop-
erties) have potential, alone or in combination with other techniques, in cell-based drug screen-
ing platforms [18,19]. One acoustic technique, the quartz crystal microbalance (QCM)
technique, has been successfully applied to studies of attachment and subsequent spreading of
cells at the surface of the QCM sensor [20,21], changes in cells exposed to cytomorphic agents
[21–23], exocytotic events in neural cells on the sensor surface [24], pigment redistribution in
melanophores [25], as well as activation of surface-confined platelets [26]. Furthermore, QCM
has been applied to detect beating of cardiomyocytes, grown in a monolayer on the sensor sur-
face [27], and to detect spontaneous beating of hPS-CMCs [28]. These findings show the po-
tential of the QCM technology as a platform for monitoring of CMCs non-invasively, in a label
free and real-time manner, aiming not only for the detection of chronotropic characteristics
such as, e.g., arrhythmias, but also for properties of the cardiomyocyte contractile machinery,
including changes of the QT interval (the time from the beginning of the Q-wave to the end of
the T-wave in the electrical cycle of the heart, i.e., the time between the electrical depolarization
and repolarization of the ventricles). Changes in the QT interval are a well-established marker
for ventricular tachyarrhythmias, e.g., torsades de pointes with a risk for sudden death [1].
This study addresses the monitoring of mechanical (viscoelastic) properties of individual
cell clusters by acoustic sensing using QCM with dissipation monitoring (QCM-D). An open
QCM-D module was used for the detection of effects induced by well-known model com-
pounds on the spontaneous beating of hPS-CMCs (see Fig 1). Chronotropic effects were
probed by addition of isoproterenol or high doses of E-4031. Low doses of E-4031 or nifede-
pine, both well-established model drugs to probe the electrochemical cycle of CMCs, were
added to examine changes in the QT interval. In addition, we also incubated the cells with cyto-
chalasin D, a potent inhibitor of actin polymerization, to independently probe for changes of
the contraction-relaxation-cycle of the CMCs.
Based on these results, we suggest QCM-D, alone or in combination with another technique
(e.g. microscopy or impedance spectroscopy), to be an attractive alternative to existing cardio-
toxicity screening platforms.
Materials and Methods
Unless otherwise stated chemicals were from commercial suppliers and used as received.
Water was purified (filtered and deionized until a resistivity of 18 MO cm) using a MilliQ unit
(Millipore, France). Nifedipine, isoproterenol (the bitartrate salt), E-4031, and cytochalasin D
were purchased from Sigma.
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Surface preparation steps of polystyrene-coated QCM-D sensors (Q-Sense AB, Sweden)
were as follows. QCM-D sensors were cleaned by a UV-O3 treatment for 5 min followed by
sterilization in 70% ethanol and rinsing with sterile water.
hPS-CMCs derived from the human embryonic stem cell line SA121 and showing molecu-
lar markers typical for cardiac cells were obtained from Cellectis AB (Göteborg, Sweden). Brief-
ly, CMCs were maintained in knockout Dulbecco’s Modified Eagle Medium (DMEM) medium
supplemented with 20% fetal bovine serum (FBS), 1mM GlutaMAX, 0.1 mM β-mercaptoetha-
nol, 1% Minimal Essential medium (MEM) non-essential amino acids, and 1% penicillin as de-
scribed previously (all components purchased from Invitrogen) [8]. For QCM-D experiments,
the sensors were placed in the central well of a humidified IVF culture dish, to keep the under-
side as clean and dry as possible during the cell attachment phase. Single clusters were posi-
tioned centrally on fibronectin coated sensors in a droplet of medium and incubated without
further interference for 4–5 days in standard cell culture conditions (5% CO2 and 95%
humidity).
The QCM-D experiments were performed using a Q-Sense instrument of the E-Series com-
bined with the open module QOM 401 (for details we refer to the supplier) and QCM-D sen-
sors with a fundamental frequency, f0, of 5 MHz (Q-Sense AB, Sweden). The sensors onto
which clusters had been grown (see above) were carefully removed from the wells of the culture
dishes and the liquid underneath the sensor (and the lower electrode) was gently blotted and
dried with tissue. Care was taken not to perturb the cluster attached to the upper electrode dur-
ing the sensor mounting steps. The experimental set-up is schematically depicted in Fig 1. All
experiments were performed at 37°C, and CMCs were immersed in liquid carefully added on
top. Spontaneous beating of hPS-CMCs immersed in medium was monitored by QCM-D for
20 min. The model compounds (and diluent controls water and DMSO) were added by careful-
ly pipetting 1 μl of stock solution to medium covering the CMCs. Measurements were recorded
at the fundamental frequency with the highest sampling rate in order to ensure detection of
Fig 1. Schematic drawing of the experimental set-up.
doi:10.1371/journal.pone.0125540.g001
Acoustical Sensing of the Cardiomyocyte Contractile Machinery
PLOS ONE | DOI:10.1371/journal.pone.0125540 May 11, 2015 3 / 10
rhythmic cell. Cluster beating (and continued attachment) was verified periodically throughout
the QCM-Dmeasurement. Mean values and sample standard deviations were calculated based
on individual experiments given in the ESI. Experiments were repeated 3 to 4 times to ensure
reproducibility.
Results and Discussion
Experiments were performed to demonstrate the potential of QCM-D for detection of drug-in-
duced chronotropic effects in beating CMCs, as well as effects on the properties of the contrac-
tion-relaxation cycle, in an attempt to monitor signals that may represent changes in the action
potential duration and the QT interval.
Chronotropic effects induced by isoproterenol or high doses of E-4031
Two model drugs (isoproterenol and E-4031), with well-established and different effects on
cardiac activity, were added, in separate experiments, to spontaneously beating CMCs to probe
for chronotropic effects. Isoproterenol is a non-selective beta-adrenergic agonist, similar to
adrenaline, and is known to increase the beating rate of stem cell-derived cardiomyocytes [29–
31] and hPS CMCs [14]. E-4031 is a specific hERG channel blocker, which has been shown to
prolong the QT-interval and to provoke arrhythmia if added at high concentration (> 100
nM) to stem cell-derived cardiomyocytes [29] or hPS CMCs [2,15,32].
Before addition of isoproterenol, we observed spontaneous beating of the cardiomyocyte
cluster with a stable beating rate of 14–15 bpm (Fig 2A, left panel). After addition of isoprotere-
nol to a final concentration of 1 μM, an immediate increase of the beating rate to 25–27 bpm
was observed (Fig 2A, right panel). A different behavior is illustrated in Fig 2B, where a high
dose of E-4031 (final concentration of 200 nM) was added to the CMC. By comparing the
QCM-D signal of the spontaneous beating of a cardiomyocyte cluster (Fig 2B, left panel) with
the beating of the same cluster after addition of 200 nM E-4031 (Fig 2B, right panel), we clearly
observe an arrhythmic beating pattern of the CMC with QCM-D.
An important objective of the present work was to investigate whether QCM-D can be used
for the characterization of a single contraction-relaxation cycle of a CMC. For this purpose, the
beating cycle was studied in more detail to allow for the detection of changes in the duration of
a single contraction-relaxation cycle. Fig 3 shows the QCM-D Δf and ΔD versus time curves of
a single beating cycle of a spontaneously beating CMC attached to the QCM-D sensor surface.
Fig 2. Detection of chronotropic effects. Frequency (top) and dissipation (bottom) time curves obtained with a spontaneously beating hPS-CMC (left
panel, A and left panel, B), before and after addition of 1 μM isoproterenol (right panel, A) and 200 nM E-4031 (right panel, B).
doi:10.1371/journal.pone.0125540.g002
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The frequency and dissipation shifts have been normalized to facilitate the comparison be-
tween different CMCs (we observed the amplitude of the QCM-D signal to vary for different
CMCs, and also during a single experiment, presumably due to evaporation of liquid in the
open QCM-D module). To help comparing single contraction cycles of the same cluster before
and after addition of compounds, the recorded data were normalized by setting the first mini-
mum of the signal to time t = 0 sec and setting the amplitude of the first maximum in each of
the QCM-D signals to 1 (i.e., at times t = tmax,f and t = tmax,D for the frequency and the dissipa-
tion shift, respectively, as indicated in Fig 3). After the first maximum at tmax, a decrease of the
signals to the baseline is observed, where in most of the experiments, a slow decrease is fol-
lowed by a fast decrease at a turning point defined as t = tturn,f and t = tturn,D. It is interesting to
note that the shape of the recorded QCM-D signal is very similar to the cyclic waveform of the
electrochemical signal (i.e., extracellular field potential) of a microelectrode array [33]. Howev-
er, we can largely exclude that QCM-D detects changes in ion concentration or the membrane
potential as such since the changes in ionic strength of the media due to Ca2+-fluxes of the beat-
ing CMC are small and the sensor surface is grounded [28]. In a previous study, the origin of
the observed QCM-D signals from cells adhered to the sensor surface where they were under-
going morphological changes was discussed [21]. In brief, it was suggested that the QCM-D
signals are mainly due to secondary, viscoelastic effects in the layer closest to the sensor surface.
One may also consider the QCM-D signal to depend on shape deformation of the hPS-CMC
caused by changes of the shear modules or the bending rigidity of the cell cluster [34]. Using
giant unilamelar liposomes as cell mimics, it has been shown that electrically induced shape de-
formation led to a frequency shift of the QCM signal, related to the bending rigidity of the lipo-
somes [35].
Effects induced by E-4031 or nifedipine, compounds with known impacts
on the CMC electrochemical cycle
Fig 4A shows how the normalized QCM-D signal of a single beating cycle of a beating CMC
changes after stepwise addition (40 nM and 60 nM) of the hERG channel blocker E-4031. We
can clearly observe a shift of tmax and tturn after addition to longer times compared to tmax and
tturn of the spontaneously beating CMC. Changes of tmax and tturn relative to the values of the
spontaneously beating CMC are summarized in Table 1. The increase of both tmax and tturn can
Fig 3. Characterization of a single beat. Frequency (left) and dissipation (right) time curves obtained with a spontaneous beating hPS-CMC (black), before
and after addition of diluent (water) control (red). Frequency and dissipation shifts are normalized by setting maxima values to 1. The first minima is set to
time t0 = 0 sec.
doi:10.1371/journal.pone.0125540.g003
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be interpreted as an increase in the action potential duration typically observed in hPS CMCs
treated with E-4031 [2,15], and may thus be used as a surrogate measure of the QT-interval.
Similarly, in Fig 4B the effect of stepwise addition of nifedepine (20 nM, 40 nM, 60 nM) to a
spontaneous beating CMC is shown (values of Δtturn are given in Table 1). In this case, a reduc-
tion in tturn is observed upon addition of the dihydropyridine calcium channel blocker that
Fig 4. Detection of drug-induced prolongation and shortening of the QT interval. Frequency (left) and dissipation (right) time curves obtained with a
spontaneous beating hPS-CMC (black), before and after stepwise addition of (A) E-4031 (green, 40 nM and blue 60 nM) and (B) nifedepine (red, 20 nM, blue,
40 nM and green, 60 nM).
doi:10.1371/journal.pone.0125540.g004
Table 1. Changes in the contraction cycle of beating CMCsmonitored by QCM-D upon the addition of E-4031 and nifedepine.a
Δtmax Δtturn
E-4031 40 nM 0.3 ± 0.2 3.0 ± 0.4 n = 3
60 nM 0.7 ± 0.2 4.6 ± 0.3 n = 3
Nifedepine 20 nM - -0.15 ± 0.02 n = 3
40 nM - -0.24 ± 0.05 n = 3
60 nM - -0.45 ± 0.13 n = 3
aRelative changes Δtmax and Δtturn are calculated as follows: Dtmax ¼ tmax;drugtmax;spontantmax;spontan and Dtturn ¼
tturn;drugtturn;spontan
tturn;spontan
.
doi:10.1371/journal.pone.0125540.t001
Acoustical Sensing of the Cardiomyocyte Contractile Machinery
PLOS ONE | DOI:10.1371/journal.pone.0125540 May 11, 2015 6 / 10
primarily blocks L-type calcium channels whilst tmax remains unaffected. Since nifedepine is
known to shorten the QT-interval[14,36] we conclude tturn to the characteristic of the QCM-D
signal related to the QT-interval.
Effects induced by cytochalasin D, known to interfere with the
cytoskeleton
In order to verify that the observed QCM-D signals are related to the contraction of the
hPS-CMC, we added cytochalasin D, a potent inhibitor of polymerization of actin, an essential
component of the cytoskeleton. In cardiomyocytes, the cytoskeleton is a critical junction for
mechanotransduction. It provides an intracellular structure for transmitting contractive forces.
In studies using single cardiomyocytes, it has been shown that the contractility of rat ventricu-
lar myocytes is significantly depressed by short-time (minutes) exposure to cytochalasin D
(40 μM) whilst only small changes of the intracellular calcium ([Ca2+]i) transient were observed
[37].
Here, spontaneously beating hPS-CMCs were exposed to 5 μM cytochalasin D to probe for
changes in the contraction-relaxation cycle. Fig 5 shows the single beating profile of the cluster
before (spontaneously beating CMC, black curve) and after addition of cytochalasin D (red
curve). The shape of the frequency signal remains essentially the same, whereas the shape of
the dissipation signal becomes less broad. The full width at half maximum (a characteristic to
describe pulse wave forms) of the dissipation signal decreases about 50% ± 14%. This shorten-
ing of the contraction-relaxation time is in good agreement with studies described above [37].
It is also interesting to note that changes in the dissipation signal were observed when the effect
of 4 μM cytochalasin D on fibroblasts was studied by QCM-D in combination with light mi-
croscopy [21]. Upon addition of the cytomorphic agent, reversible (upon rinsing) changes in
the dissipation were observed whilst the frequency stayed essentially constant. We assume that
the observation that addition of cytochalasin D leads to changes in the dissipation, but not in
frequency, is attributed to changes of the viscoelastic properties of the cells due to rupture of
actin filaments. This assumption is supported by a recent study of Wu et al. showing by means
of AFM that cytochalasin D leads to a 85% reduction of stiffness of cardiomyocytes [38]. We
also note the correspondence with a previous study of the effects of cytoskeletal drugs on
Fig 5. Effect of cytochalasin D. Representative frequency (left) and dissipation (right) time curves obtained with a spontaneous beating hPS-CMC (black),
before and after addition of 5 μM cytochalasin D (red). The full width at half maximum of the dissipation signal decreases about 50% ± 14% (calculated by a
set of three experiments). The value of the full width at half maximum is given by the difference between the two times at which the frequency and dissipation
shifts, respectively, is equal to half of its maximum value.
doi:10.1371/journal.pone.0125540.g005
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melanophores, where drug-induced changes in the actin layers were readily detected by
QCM-D [25].
Taken together, our results suggest that acoustic sensing can be applied to single CMCs for
surrogate measuring of the QT interval and other characteristics of the contractile machinery.
These findings suggest that QCM-D has great potential as a tool for cardiotoxicological screen-
ing, where effects of compounds on the cardiomyocyte contractile machinery can be detected
independently of whether the extracellular field potential is altered or not. In order to increase
throughput and to reduce noise in the assay, the experimental set-up would need to be devel-
oped further, in particular with respect to liquid handling.
Conclusion
We have demonstrated that QCM-D provides a versatile tool to study drug-induced effects on
the contractile machinery, including chronotropic effects, prolongation and shortening of the
QT-interval, as well as the effect of cytochalasin D on the contraction-relaxation cycles. Thus,
effects of compounds on the cardiomyocyte contractile machinery can be detected indepen-
dently of whether the extracellular field potential is altered or not. Our findings suggest great
potential of QCM-D for cardiotoxicological screening.
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